DK169609B1 - Anvendelse af 4-substituerede indoloner til fremstilling af medikamenter til behandling af Parkinsons sygdom - Google Patents
Anvendelse af 4-substituerede indoloner til fremstilling af medikamenter til behandling af Parkinsons sygdom Download PDFInfo
- Publication number
- DK169609B1 DK169609B1 DK275488A DK275488A DK169609B1 DK 169609 B1 DK169609 B1 DK 169609B1 DK 275488 A DK275488 A DK 275488A DK 275488 A DK275488 A DK 275488A DK 169609 B1 DK169609 B1 DK 169609B1
- Authority
- DK
- Denmark
- Prior art keywords
- compound
- disease
- treatment
- parkinson
- hydrogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878712073A GB8712073D0 (en) | 1987-05-21 | 1987-05-21 | Medicament |
GB8712073 | 1987-05-21 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK275488D0 DK275488D0 (da) | 1988-05-19 |
DK275488A DK275488A (da) | 1988-11-22 |
DK169609B1 true DK169609B1 (da) | 1994-12-27 |
Family
ID=10617727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK275488A DK169609B1 (da) | 1987-05-21 | 1988-05-19 | Anvendelse af 4-substituerede indoloner til fremstilling af medikamenter til behandling af Parkinsons sygdom |
Country Status (21)
Country | Link |
---|---|
US (2) | US4824860A (hu) |
EP (1) | EP0299602B1 (hu) |
JP (1) | JPH062672B2 (hu) |
AT (1) | ATE83659T1 (hu) |
AU (1) | AU599792B2 (hu) |
CA (1) | CA1305421C (hu) |
DE (1) | DE3876877T2 (hu) |
DK (1) | DK169609B1 (hu) |
ES (1) | ES2052717T3 (hu) |
GB (1) | GB8712073D0 (hu) |
GR (1) | GR3007251T3 (hu) |
HK (1) | HK1000913A1 (hu) |
HU (1) | HU201871B (hu) |
IE (1) | IE63511B1 (hu) |
LU (1) | LU90098I2 (hu) |
MX (1) | MX9203543A (hu) |
NL (1) | NL970006I2 (hu) |
NZ (1) | NZ224709A (hu) |
PH (1) | PH23867A (hu) |
PT (1) | PT87542B (hu) |
ZA (1) | ZA883602B (hu) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9008605D0 (en) * | 1990-04-17 | 1990-06-13 | Smith Kline French Lab | Process |
GB9015095D0 (en) * | 1990-07-09 | 1990-08-29 | Smith Kline French Lab | Therapeutic method |
AU4312593A (en) * | 1992-05-18 | 1993-12-13 | Smithkline Beecham Plc | Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease |
GB9300309D0 (en) * | 1993-01-08 | 1993-03-03 | Smithkline Beecham Plc | Process |
GB9511366D0 (en) * | 1995-06-06 | 1995-08-02 | Smithkline Beecham Plc | Novel formulations |
GB9517062D0 (en) * | 1995-08-18 | 1995-10-25 | Scherer Ltd R P | Pharmaceutical compositions |
US5807570A (en) * | 1995-09-29 | 1998-09-15 | Cygnus, Inc. | Transdermal administration of ropinirole and analogs thereof |
GB9612752D0 (en) * | 1996-06-19 | 1996-08-21 | Smithkline Beecham Plc | Novel treatment |
PT923551E (pt) * | 1996-08-27 | 2002-09-30 | American Home Prod | Derivados de 4-aminoetoxi indolona |
CA2327477A1 (en) * | 1998-04-13 | 1999-10-21 | James Albert Nelson | 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists |
US6176242B1 (en) | 1999-04-30 | 2001-01-23 | Medtronic Inc | Method of treating manic depression by brain infusion |
US6218421B1 (en) * | 1999-07-01 | 2001-04-17 | Smithkline Beecham P.L.C. | Method of promoting smoking cessation |
AR030557A1 (es) * | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
US6277875B1 (en) * | 2000-07-17 | 2001-08-21 | Andrew J. Holman | Use of dopamine D2/D3 receptor agonists to treat fibromyalgia |
DE10041478A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
US7858602B2 (en) * | 2000-10-16 | 2010-12-28 | Rodriguez Victorio C | Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells |
US6871098B2 (en) * | 2000-10-30 | 2005-03-22 | Medtronic, Inc. | Method for treating obsessive-compulsive disorder with electrical stimulation of the brain internal capsule |
ES2285245T3 (es) * | 2002-09-13 | 2007-11-16 | Motac Neuroscience Limited | Tratamiento de la disquinesia con 2,3-benzodiazapinas. |
AU2003267557B2 (en) * | 2002-09-17 | 2009-02-26 | Motac Neuroscience Limited | Treatment of dyskinesia |
DE10334187A1 (de) * | 2003-07-26 | 2005-03-03 | Schwarz Pharma Ag | Substituierte 2-Aminotetraline zur Behandlung von Depressionen |
DE10334188B4 (de) * | 2003-07-26 | 2007-07-05 | Schwarz Pharma Ag | Verwendung von Rotigotin zur Behandlung von Depressionen |
WO2005051488A1 (en) * | 2003-11-26 | 2005-06-09 | Pfizer Products Inc. | Combination of dopamine agonists and monoamine reuptake inhibitors |
DE10361258A1 (de) * | 2003-12-24 | 2005-07-28 | Schwarz Pharma Ag | Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson |
US7378439B2 (en) * | 2004-01-20 | 2008-05-27 | Usv, Ltd. | Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride |
US20050197385A1 (en) * | 2004-02-20 | 2005-09-08 | Schwarz Pharma Ag | Use of rotigotine for treatment or prevention of dopaminergic neuron loss |
DE102004014841B4 (de) * | 2004-03-24 | 2006-07-06 | Schwarz Pharma Ag | Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms |
WO2007048034A2 (en) * | 2005-10-21 | 2007-04-26 | Caritas St. Elizabeth Medical Center Of Boston, Inc. | Use of androgens for the treatment of parkinson' s disease |
US8475829B2 (en) * | 2006-04-06 | 2013-07-02 | Nupathe Inc. | Implants for the treatment of dopamine associated states |
WO2008001204A2 (en) * | 2006-06-29 | 2008-01-03 | Antares Pharma Ipl Ag | Transdermal compositions of pramipexole having enhanced permeation properties |
TW200815045A (en) * | 2006-06-29 | 2008-04-01 | Jazz Pharmaceuticals Inc | Pharmaceutical compositions of ropinirole and methods of use thereof |
US20090247537A1 (en) * | 2008-03-25 | 2009-10-01 | William Dale Overfield | Methods for preventing or treating bruxism using dopaminergic agents |
CN101574341B (zh) * | 2008-05-05 | 2012-12-19 | 北京德众万全医药科技有限公司 | 一种罗匹尼罗的口服固体药物组合物 |
WO2010023693A2 (en) * | 2008-09-01 | 2010-03-04 | Lupin Limited | Novel controlled release compositions of ropinirole |
CA2738414C (en) | 2008-09-29 | 2014-05-27 | Wockhardt Research Centre | Extended release dosage form of ropinirole |
WO2010044108A2 (en) | 2008-10-17 | 2010-04-22 | Rubicon Research Private Limited | Controlled release formulations of ropinirole |
US20100233259A1 (en) * | 2008-12-12 | 2010-09-16 | Pascal Grenier | Dosage form of ropinirole |
UA103851C2 (en) | 2010-04-30 | 2013-11-25 | ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. | Propylaminoindan transdermal composition |
WO2012129429A2 (en) | 2011-03-24 | 2012-09-27 | Teikoku Pharma Usa, Inc. | Transdermal compositions comprising an active agent layer and an active agent conversion layer |
JP5913614B2 (ja) | 2011-11-09 | 2016-04-27 | テイコク ファーマ ユーエスエー インコーポレーテッド | 皮膚新生物の処置方法 |
WO2014070622A1 (en) | 2012-11-02 | 2014-05-08 | Teikoku Pharma Usa, Inc. | Propynylaminoindan transdermal compositions |
WO2015168616A1 (en) * | 2014-05-02 | 2015-11-05 | Abbvie Inc. | Neuronal nicotinic agonists and methods of use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4452808A (en) * | 1982-12-07 | 1984-06-05 | Smithkline Beckman Corporation | 4-Aminoalkyl-2(3H)-indolones |
US4588740A (en) * | 1982-12-07 | 1986-05-13 | Smithkline Beckman Corporation | Pharmaceutical methods using 4-aminoalkyl-2(3H)-indolones |
-
1987
- 1987-05-21 GB GB878712073A patent/GB8712073D0/en active Pending
-
1988
- 1988-05-16 IE IE146988A patent/IE63511B1/en not_active IP Right Cessation
- 1988-05-16 PH PH36934A patent/PH23867A/en unknown
- 1988-05-17 CA CA000566974A patent/CA1305421C/en not_active Expired - Lifetime
- 1988-05-19 AT AT88304555T patent/ATE83659T1/de active
- 1988-05-19 DK DK275488A patent/DK169609B1/da not_active IP Right Cessation
- 1988-05-19 ES ES88304555T patent/ES2052717T3/es not_active Expired - Lifetime
- 1988-05-19 AU AU16445/88A patent/AU599792B2/en not_active Expired
- 1988-05-19 DE DE8888304555T patent/DE3876877T2/de not_active Expired - Lifetime
- 1988-05-19 EP EP88304555A patent/EP0299602B1/en not_active Expired - Lifetime
- 1988-05-19 US US07/196,653 patent/US4824860A/en not_active Expired - Lifetime
- 1988-05-19 NZ NZ224709A patent/NZ224709A/en unknown
- 1988-05-20 ZA ZA883602A patent/ZA883602B/xx unknown
- 1988-05-20 HU HU882611A patent/HU201871B/hu unknown
- 1988-05-20 JP JP63124816A patent/JPH062672B2/ja not_active Expired - Lifetime
- 1988-05-20 PT PT87542A patent/PT87542B/pt not_active IP Right Cessation
-
1989
- 1989-03-13 US US07/322,386 patent/US4912126A/en not_active Expired - Lifetime
-
1992
- 1992-06-26 MX MX9203543A patent/MX9203543A/es unknown
-
1993
- 1993-03-05 GR GR930400472T patent/GR3007251T3/el unknown
-
1997
- 1997-02-05 NL NL970006C patent/NL970006I2/xx unknown
- 1997-07-16 LU LU90098C patent/LU90098I2/fr unknown
- 1997-12-19 HK HK97102520A patent/HK1000913A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1000913A1 (en) | 1998-05-08 |
NL970006I1 (nl) | 1997-04-01 |
MX9203543A (es) | 1992-07-01 |
AU599792B2 (en) | 1990-07-26 |
NL970006I2 (nl) | 1997-10-01 |
EP0299602A2 (en) | 1989-01-18 |
US4912126A (en) | 1990-03-27 |
NZ224709A (en) | 1997-02-24 |
HU201871B (en) | 1991-01-28 |
HUT47217A (en) | 1989-02-28 |
US4824860A (en) | 1989-04-25 |
GR3007251T3 (hu) | 1993-07-30 |
EP0299602A3 (en) | 1990-06-06 |
PT87542B (pt) | 1992-09-30 |
AU1644588A (en) | 1988-11-24 |
PT87542A (pt) | 1989-05-31 |
DK275488A (da) | 1988-11-22 |
EP0299602B1 (en) | 1992-12-23 |
LU90098I2 (fr) | 1997-09-25 |
CA1305421C (en) | 1992-07-21 |
IE63511B1 (en) | 1995-05-03 |
GB8712073D0 (en) | 1987-06-24 |
JPS63303966A (ja) | 1988-12-12 |
ATE83659T1 (de) | 1993-01-15 |
DE3876877T2 (de) | 1993-04-29 |
JPH062672B2 (ja) | 1994-01-12 |
DE3876877D1 (de) | 1993-02-04 |
IE881469L (en) | 1988-11-21 |
ES2052717T3 (es) | 1994-07-16 |
ZA883602B (en) | 1989-04-26 |
PH23867A (en) | 1989-11-23 |
DK275488D0 (da) | 1988-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK169609B1 (da) | Anvendelse af 4-substituerede indoloner til fremstilling af medikamenter til behandling af Parkinsons sygdom | |
Baldessarini et al. | Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs | |
JP5582535B2 (ja) | 点眼投与による神経疾患または精神神経疾患の治療または予防 | |
CA2134038C (en) | Potentiation of drug response | |
US20080167366A1 (en) | Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug | |
PT2083811T (pt) | Métodos de tratamento da síndrome de down, síndrome do x frágil e autismo | |
EA015514B1 (ru) | Применение бензоконденсированных гетероциклических сульфамидных производных для лечения маниакального синдрома и биполярного расстройства | |
KR20130101545A (ko) | 운동 장애 치료를 위한 세로토닌 수용체 작용제의 조합 | |
MXPA01009963A (es) | Metodo para el tratamiento de padecimientos neurologicos o neuropsiquiatricos. | |
JP2019001798A (ja) | 活動意欲向上剤 | |
CN107635555A (zh) | 丁螺环酮代谢物的用途 | |
Korsgaard et al. | The Effect of Tetrahydroisoxazolopyridinol (THIP) in Tardive Dyskinesia: A New β-Aminobutyric Acid Agonist | |
KR20030053475A (ko) | 5-ht3 및 신경세포의 니코틴작용성 수용체 길항물질로서의 1-아미노-알킬시클로헥산 화합물을 이용한 치료방법 및 이 화합물을 함유하는 약학적 조성물 | |
CN103889408A (zh) | S1p受体调节剂或激动剂的剂量方案 | |
WO2002067927A1 (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
AU2002242296A1 (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
CN101584692A (zh) | 左旋千金藤啶碱(l-SPD)衍生物的用途 | |
CN101167714A (zh) | 一种治疗男性勃起功能障碍的药物 | |
Weiner et al. | Dopaminergic antagonism of L‐5‐hydroxytryptophan‐induced myoclonic jumping behavior | |
JPH09500375A (ja) | パーキンソン病の治療を目的とする医薬品の製造のためのエファロキサンおよびその誘導体の使用 | |
EP1518554B1 (en) | Pharmaceutical composition for the treatment of hyperhomocysteinemia | |
Macht | ACTION OF THE OPIUM ALKALOIDS: INDIVIDUALLY AND IN COMBINATION WITH EACH OTHER ON THE CORONARY ARTERY AND THE CORONARY CIRCULATION | |
Saidi et al. | Science Repository | |
WO2024052880A1 (en) | Use of mdma for treatment of stress-related disorders | |
Dickinson et al. | Effects of idazoxan on 5-hydroxytryptamine-mediated behaviour in the mouse and rat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
CTFF | Application for supplementary protection certificate (spc) filed |
Free format text: CA 1997 00011, 970131 |
|
CTFG | Supplementary protection certificate (spc) issued |
Free format text: CA 1997 00011, 970131, EXPIRES: 20110702 |
|
PUP | Patent expired |